Information Journal Paper
APA:
Copy. (2018). Dapagliflozin improves blood glucose in diabetes on triple oral hypoglycemic agents having inadequate glucose control. JOURNAL OF DIABETES RESEARCH AND CLINICAL PRACTICE, 142(-), 188-194. SID. https://sid.ir/paper/704165/en
Vancouver:
Copy. Dapagliflozin improves blood glucose in diabetes on triple oral hypoglycemic agents having inadequate glucose control. JOURNAL OF DIABETES RESEARCH AND CLINICAL PRACTICE[Internet]. 2018;142(-):188-194. Available from: https://sid.ir/paper/704165/en
IEEE:
Copy, “Dapagliflozin improves blood glucose in diabetes on triple oral hypoglycemic agents having inadequate glucose control,” JOURNAL OF DIABETES RESEARCH AND CLINICAL PRACTICE, vol. 142, no. -, pp. 188–194, 2018, [Online]. Available: https://sid.ir/paper/704165/en